Reducing false alarms in syndromic surveillance.

Abstract:

:Algorithms for identifying public health threats or disease outbreaks are vulnerable to false alarms arising from sudden shifts in health-care utilization or data participation. This paper describes a method of reducing false alerts in automated public health surveillance algorithms, and in particular, automated syndromic surveillance algorithms, that rely on health-care utilization data. The technique is based on monitoring syndromic counts with reference to a suitable background, or reference, series of counts. The suitability of the background time series in decreasing the false-alarm rate will be shown to be related mathematically to the so-called mutual information that exists between the random variables representing the syndromic and background time series of counts. The method can be understood as a noise cancellation filter technique in which one noisy (reference) channel is used to cancel the background noise of the monitored (measured) channel. The issues discussed here may also be relevant to the appropriate use of rates in epidemiology and biostatistics.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Peter W,Najmi AH,Burkom HS

doi

10.1002/sim.4204

subject

Has Abstract

pub_date

2011-06-30 00:00:00

pages

1665-77

issue

14

eissn

0277-6715

issn

1097-0258

journal_volume

30

pub_type

杂志文章
  • Multinomial goodness-of-fit tests for logistic regression models.

    abstract::We examine the properties of several tests for goodness-of-fit for multinomial logistic regression. One test is based on a strategy of sorting the observations according to the complement of the estimated probability for the reference outcome category and then grouping the subjects into g equal-sized groups. A g x c c...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3202

    authors: Fagerland MW,Hosmer DW,Bofin AM

    更新日期:2008-09-20 00:00:00

  • Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance.

    abstract::In the last decade or so, pharmaceutical drug development activities in the area of new antibacterial drugs for treating serious bacterial diseases have declined, and at the same time, there are worries that the increased prevalence of antibiotic-resistant bacterial infections, especially the increase in drug-resistan...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6233

    authors: Huque MF,Valappil T,Soon GG

    更新日期:2014-11-10 00:00:00

  • Modeling health survey data with excessive zero and K responses.

    abstract::Zero-inflated Poisson regression is a popular tool used to analyze data with excessive zeros. Although much work has already been performed to fit zero-inflated data, most models heavily depend on special features of the individual data. To be specific, this means that there is a sizable group of respondents who endor...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5650

    authors: Lin TH,Tsai MH

    更新日期:2013-04-30 00:00:00

  • Subgroup identification from randomized clinical trial data.

    abstract::We consider the problem of identifying a subgroup of patients who may have an enhanced treatment effect in a randomized clinical trial, and it is desirable that the subgroup be defined by a limited number of covariates. For this problem, the development of a standard, pre-determined strategy may help to avoid the well...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4322

    authors: Foster JC,Taylor JM,Ruberg SJ

    更新日期:2011-10-30 00:00:00

  • The probability of a cancer cluster due to chance alone.

    abstract::We propose to use a very simple model to test whether a cancer cluster is due to chance alone. We focus on the acute childhood leukaemia cluster in Columbus, Ohio. In 1975, 12 leukaemia cases were observed in Columbus while the expected number is 6 cases per year. According to our simple model, the probability of such...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/1097-0258(20000830)19:16<2195::aid-sim522>

    authors: Schinazi RB

    更新日期:2000-08-30 00:00:00

  • Reinforcement learning design for cancer clinical trials.

    abstract::We develop reinforcement learning trials for discovering individualized treatment regimens for life-threatening diseases such as cancer. A temporal-difference learning method called Q-learning is utilized that involves learning an optimal policy from a single training set of finite longitudinal patient trajectories. A...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3720

    authors: Zhao Y,Kosorok MR,Zeng D

    更新日期:2009-11-20 00:00:00

  • A model for space-time cluster detection using spatial clusters with flexible temporal risk patterns.

    abstract::Maps of estimated disease rates over multiple time periods are useful tools for gaining etiologic insights regarding potential exposures associated with specific locations and times. In this paper, we describe an extension of the Gangnon-Clayton model for spatial clustering to spatio-temporal data. As in the purely sp...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3984

    authors: Gangnon RE

    更新日期:2010-09-30 00:00:00

  • Weighted multiple testing correction for correlated tests.

    abstract::Virtually all clinical trials collect multiple endpoints that are usually correlated. Many methods have been proposed to control the family-wise type I error rate (FWER), but these methods often disregard the correlation among the endpoints, such as the commonly used Bonferroni correction, Holm procedure, Wiens' Bonfe...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4434

    authors: Xie C

    更新日期:2012-02-20 00:00:00

  • Sample size calculation for stepped wedge and other longitudinal cluster randomised trials.

    abstract::The sample size required for a cluster randomised trial is inflated compared with an individually randomised trial because outcomes of participants from the same cluster are correlated. Sample size calculations for longitudinal cluster randomised trials (including stepped wedge trials) need to take account of at least...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7028

    authors: Hooper R,Teerenstra S,de Hoop E,Eldridge S

    更新日期:2016-11-20 00:00:00

  • Ratio of geometric means to analyze continuous outcomes in meta-analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation.

    abstract::Meta-analyses pooling continuous outcomes can use mean differences (MD), standardized MD (MD in pooled standard deviation units, SMD), or ratio of arithmetic means (RoM). Recently, ratio of geometric means using ad hoc (RoGM (ad hoc) ) or Taylor series (RoGM (Taylor) ) methods for estimating variances have been propos...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4501

    authors: Friedrich JO,Adhikari NK,Beyene J

    更新日期:2012-07-30 00:00:00

  • Power and sample size calculation for log-rank test with a time lag in treatment effect.

    abstract::The log-rank test is the most powerful non-parametric test for detecting a proportional hazards alternative and thus is the most commonly used testing procedure for comparing time-to-event distributions between different treatments in clinical trials. When the log-rank test is used for the primary data analysis, the s...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3501

    authors: Zhang D,Quan H

    更新日期:2009-02-28 00:00:00

  • Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: application to clinical trial data on chronic lymphocytic leukaemia.

    abstract::In clinical research, we are often interested in assessing how a biomarker changes with time, and whether it could be used as a surrogate marker when evaluating the efficacy of a new drug. However, when the longitudinal marker is correlated with survival, linear mixed models for longitudinal data may be inappropriate....

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3142

    authors: Deslandes E,Chevret S

    更新日期:2007-12-30 00:00:00

  • Identifying representative trees from ensembles.

    abstract::Tree-based methods have become popular for analyzing complex data structures where the primary goal is risk stratification of patients. Ensemble techniques improve the accuracy in prediction and address the instability in a single tree by growing an ensemble of trees and aggregating. However, in the process, individua...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4492

    authors: Banerjee M,Ding Y,Noone AM

    更新日期:2012-07-10 00:00:00

  • Use of max and min scores for trend tests for association when the genetic model is unknown.

    abstract::In case-control studies, the Cochran-Armitage (CA) trend test is powerful for detection of an association between a risk allele and a marker. To apply this test, a score should be assigned to the genotypes based on the genetic model. When the underlying genetic model is unknown, the trend test statistic is a function ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1474

    authors: Zheng G

    更新日期:2003-08-30 00:00:00

  • Sample sizes for constructing confidence intervals and testing hypotheses.

    abstract::Although estimation and confidence intervals have become popular alternatives to hypothesis testing and p-values, statisticians usually determine sample sizes for randomized clinical trials by controlling the power of a statistical test at an appropriate alternative, even those statisticians who recommend the use of c...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780080705

    authors: Bristol DR

    更新日期:1989-07-01 00:00:00

  • Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.

    abstract::Sequential analysis is frequently employed to address ethical and financial issues in clinical trials. Sequential analysis may be performed using standard group sequential designs, or, more recently, with adaptive designs that use estimates of treatment effect to modify the maximal statistical information to be collec...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4156

    authors: Emerson SC,Rudser KD,Emerson SS

    更新日期:2011-05-20 00:00:00

  • Assessing the incremental predictive performance of novel biomarkers over standard predictors.

    abstract::It is unclear to what extent the incremental predictive performance of a novel biomarker is impacted by the method used to control for standard predictors. We investigated whether adding a biomarker to a model with a published risk score overestimates its incremental performance as compared to adding it to a multivari...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6165

    authors: Xanthakis V,Sullivan LM,Vasan RS,Benjamin EJ,Massaro JM,D'Agostino RB Sr,Pencina MJ

    更新日期:2014-07-10 00:00:00

  • Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement error.

    abstract::In biomedical research such as the development of vaccines for infectious diseases or cancer, study outcomes measured by an assay or device are often collected from multiple sources or laboratories. Measurement error that may vary between laboratories needs to be adjusted for when combining samples across data sources...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5446

    authors: Huang Y,Huang Y,Moodie Z,Li S,Self S

    更新日期:2012-12-10 00:00:00

  • On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference.

    abstract::Propensity score analysis is widely used in observational studies to adjust for confounding and estimate the causal effect of a treatment on the outcome. When the outcome is survival time, there are special considerations on the definition of the causal estimand, point, and variance estimation that have not been thoro...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7839

    authors: Mao H,Li L,Yang W,Shen Y

    更新日期:2018-11-20 00:00:00

  • Model averaging for robust assessment of QT prolongation by concentration-response analysis.

    abstract::Assessing the QT prolongation potential of a drug is typically done based on pivotal safety studies called thorough QT studies. Model-based estimation of the drug-induced QT prolongation at the estimated mean maximum drug concentration could increase efficiency over the currently used intersection-union test. However,...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7395

    authors: Dosne AG,Bergstrand M,Karlsson MO,Renard D,Heimann G

    更新日期:2017-10-30 00:00:00

  • Racial/ethnic disparities in vaccination coverage by 19 months of age: an evaluation of the impact of missing data resulting from record scattering.

    abstract::We describe how trends in the vaccination coverage at 19 months of age vary by race/ethnicity; explore the extent to which data required to evaluate a child's up-to-date vaccination status is missing as a result of the scattering of vaccination records among many vaccination providers; evaluate how the prevalence of t...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3223

    authors: Smith PJ,Stevenson J

    更新日期:2008-09-10 00:00:00

  • Scientific considerations for assessing biosimilar products.

    abstract::The problem for assessing biosimilarity and drug interchangeability of follow-on biologics (biosimilar products) is studied. Unlike the generic products, the development of biosimilar products is much more complicated because of fundamental differences in functional structures and manufacturing processes. As a result,...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5571

    authors: Chow SC,Wang J,Endrenyi L,Lachenbruch PA

    更新日期:2013-02-10 00:00:00

  • Technical uncertainty in the back-calculation of occupational exposure to dioxins.

    abstract::Members of a cohort of workers in chemical industry (the so-called Boehringer cohort) exposed to 2, 3, 7, 8-tetrachlorodibenzo-para-dioxin (TCDD) from 1950 to 1984 were subject in the years 1985-1986 and 1992-1994 to an extensive biomonitoring programme on the TCDD levels of the individual workers. For establishing a ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3074

    authors: Heinzl H,Mittlböck M,Edler L

    更新日期:2008-05-30 00:00:00

  • Variance estimation of a survival function for interval-censored survival data.

    abstract::Interval-censored survival data often occur in medical studies, especially in clinical trials. In this case, many authors have considered estimation of a survival function. There is, however, relatively little discussion on estimating the variance of estimated survival functions. For right-censored data, a special cas...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.719

    authors: Sun J

    更新日期:2001-04-30 00:00:00

  • A model for cross-over trials evaluating therapeutic preferences.

    abstract::A preference trial is a special form of cross-over trial where clinical conditions determine when patients change treatment, in a prescribed order. This can be modelled using a geometric distribution. The model can be simply fitted using standard logistic regression methodology. The procedure is applied to a trial stu...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0258(19960229)15:4<443::AID-SIM

    authors: Lindsey JK,Jones B

    更新日期:1996-02-28 00:00:00

  • Designs for phase I trials in ordered groups.

    abstract::We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7133

    authors: Conaway MR,Wages NA

    更新日期:2017-01-30 00:00:00

  • Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: methods and challenges.

    abstract::Novel therapies are challenging the standards of drug development. Agents with specific biologic targets, unknown dose-efficacy curves, and limited toxicity mandate novel designs to identify biologically optimal doses. We review two model-based designs that utilize either a proportional odds model or a continuation ra...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3706

    authors: Mandrekar SJ,Qin R,Sargent DJ

    更新日期:2010-05-10 00:00:00

  • Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center.

    abstract::To benefit Alzheimer's disease research, a central data co-ordinating centre (CDCC) is planned that will systematically collect data from 27 Alzheimer's disease centres (ADCs) located nationwide. This CDCC will combine, analyse and disseminate epidemiologic, demographic, clinical and neuropathological data to research...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1453:

    authors: Cronin-Stubbs D,DeKosky ST,Morris JC,Evans DA

    更新日期:2000-06-15 00:00:00

  • An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

    abstract::In a phase I clinical trial in cancer patients, the drug involved had one known main adverse effect, which also occurs spontaneously in cancer patients with a fairly high frequency. Experiments in rats have shown marked effects of the drug on tumour growth in high doses, but also dose-dependent toxicity. Consequently,...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780140909

    authors: Møller S

    更新日期:1995-05-15 00:00:00

  • Precision of incidence predictions based on Poisson distributed observations.

    abstract::Disease incidence predictions are useful for a number of administrative and scientific purposes. The simplest ones are made using trend extrapolation, on either an arithmetic or a logarithmic scale. This paper shows how approximate confidence prediction intervals can be calculated for such predictions, both for the to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780131503

    authors: Hakulinen T,Dyba T

    更新日期:1994-08-15 00:00:00